ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,070.82
-0.89%
US Tech 100
17,118.40
-1.11%
다우존스 지수
37,986.39
-1.04%
Bitcoin
60,171.58
-5.74%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Marinus Pharmaceuticals Inc (MRNS)

  7. Marinus Pharmaceuticals Inc (MRNS) 뉴스

MRNS Marinus Pharmaceuticals Inc

1.425
0.025 (1.79%)
최종 업데이트: 03:27:09
15분 지연
기업명 주식 심볼 시장 주식 타입
Marinus Pharmaceuticals Inc MRNS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.025 1.79% 1.425 03:27:09
개장가 저가 고가 종가 전일 종가
1.42 1.39 1.43 1.40
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
15/04/202420:00BWMarinus Pharmaceuticals Provides Update on the Phase 3 RAISE..
06/04/202405:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
27/03/202421:41BWMarinus Pharmaceuticals Comments on Patent Challenge by Ovid..
06/03/202406:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/03/202406:01BWMarinus Pharmaceuticals Provides Business Update and Reports..
23/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202421:00BWMarinus Pharmaceuticals to Present at Upcoming Investor..
20/02/202421:00BWMarinus Pharmaceuticals to Provide Business Update and..
17/02/202406:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
15/02/202406:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202405:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202402:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202400:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202423:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202402:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/01/202406:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
04/01/202421:04EDGAR2Form 8-K - Current report
04/01/202421:01BWMarinus Pharmaceuticals Reports Preliminary Fourth Quarter..
08/12/202306:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
28/11/202321:05EDGAR2Form 8-K - Current report
21/11/202306:01BWMarinus Pharmaceuticals Announces Seven Presentations at AES..
15/11/202306:05BWMarinus Pharmaceuticals to Present at the 6th Annual..
10/11/202306:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
07/11/202321:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:11EDGAR2Form 8-K - Current report
07/11/202321:01BWMarinus Pharmaceuticals Provides Business Update and Reports..
07/11/202321:00BWMarinus Pharmaceuticals Initiates Global Access Program for..
24/10/202320:01BWMarinus Pharmaceuticals to Provide Business Update and..
11/10/202305:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/10/202305:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
28/09/202320:05EDGAR2Form 8-K - Current report
22/09/202305:00BWMarinus Pharmaceuticals to Present at the 2023 Cantor Global..
19/09/202321:02EDGAR2Form 8-K - Current report
19/09/202321:00BWMarinus Pharmaceuticals Highlights Advancing Pipeline and..
13/09/202305:00BWMarinus Pharmaceuticals Announces Speakers for Hybrid..
07/09/202305:01BWMarinus Pharmaceuticals Announces Inducement Grants Under..

최근 히스토리

NASDAQ
MRNS
Marinus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유